SCHEMBL6178971

SCHEMBL6178971

CCOC(=S)Cc1cccc(N)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.43
TP53 P04637 1/20 0.43
MAOB P27338 3/20 0.42
MAOA P21397 3/20 0.42
CYP19A1 P11511 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
OPRK1 P41145 1/20 0.36
CASP1 P29466 1/20 0.35
RECQL P46063 1/20 0.35
GLS O94925 1/20 0.35
ALDH1A1 P00352 2/20 0.35
LMNA P02545 2/20 0.35
CYP1A2 P05177 1/20 0.35
TSHR P16473 1/20 0.35
MAPT P10636 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
ELANE P08246 1/20 0.34
KDM4E B2RXH2 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6178783 0.82 MAOB (0.50) MAOBMAOACYP19A1SMN1; SMN2ALDH1A1
SCHEMBL274133 0.80 SMN1; SMN2 (0.46) CYP3A4TP53MAOBMAOASMN1; SMN2
SCHEMBL28472471 0.80 IDO1 (0.43) MAOBCYP19A1CYP1A2L3MBTL1
SCHEMBL8115025 0.80 ALDH1A1 (0.41) CYP3A4MAOBMAOACYP19A1CASP1
SCHEMBL9742546 0.79 CYP3A4 (0.47) CYP3A4MAOASMN1; SMN2ALDH1A1LMNA
Hydrochloric Acid SCHEMBL274132 0.79 SMN1; SMN2 (0.45) CYP3A4TP53MAOBMAOASMN1; SMN2
SCHEMBL6178741 0.79 MAOB (0.41) CYP3A4TP53MAOBMAOACYP19A1
SCHEMBL11632694 0.78 CYP3A4 (0.39) CYP3A4TP53MAOBMAOACYP19A1
SCHEMBL3251246 0.78 ALDH1A1 (0.44) TP53SMN1; SMN2ALDH1A1LMNATSHR
Hydrochloric Acid SCHEMBL8865281 0.77 CYP3A4 (0.46) CYP3A4MAOBMAOASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0945445-B9 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARM CO LTD (JP) 2005-12-28 EP disclosed
CN-1130351-C 1,5-benzodiazepine derivatives ZERIA PHARM CO LTD (JP) 2003-12-10 CN disclosed
EP-0945445-B1 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARM CO LTD (JP) 2003-09-03 EP disclosed
EP-0728748-B1 BENZODIAZEPINE DERIVATIVES SHIONOGI & CO (JP) 2002-03-06 EP disclosed
US-6239131-B1 WHICH HAVE GASTRIN AND/OR CCK-B (CHOLECYSTOKININ-B) RECEPTOR ANTAGONISM, USEFUL AS REMEDIES FOR GASTRIC ULCER AND GASTROINTESTINAL MOVEMENT DISORDER. ZERIA PHARMACEUTICAL CO., LTD. (JP) 2001-05-29 US disclosed
CN-1246850-A 1,5-benzodiazepine derivatives ZERIA PHARM CO LTD (JP) 2000-03-08 CN disclosed
EP-0945445-A1 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARMACEUTICAL CO., LTD. (JP) 1999-09-29 EP disclosed
US-5776929-A GASTRIN INHIBITOR; GASTROINTESTINAL DISORDERS SHIONOGI & CO., LTD. (JP) 1998-07-07 US disclosed
EP-0728748-A1 NOVEL BENZODIAZEPINE DERIVATIVE SHIONOGI & CO., LTD. (JP) 1996-08-28 EP disclosed
US-5382590-A Gastrointestinal disorders and nervous system disorders RHONE-POULENC RORER S.A. (FR) 1995-01-17 US disclosed